3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
120
Carboplatin
114
Pemetrexed
74
Cisplatin
71
Nivolumab
68
Paclitaxel
58
Docetaxel
56
Radiotherapy
41
Erlotinib Hydrochloride
41
Gemcitabine
35
Etoposide
34
atezolizumab
30
osimertinib
29
Cetuximab
27
Ipilimumab
25
Bevacizumab
25
Radiosurgery
22
durvalumab
21
Cyclophosphamide
20
Drug Therapy
18
130-nm albumin-bound paclitaxel
17
avelumab
14
Taxes
14
Gefitinib
14
Albumin-Bound Paclitaxel
14
Irinotecan
13
Injections
13
fludarabine
11
Radiation
11
cemiplimab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Immunoglobulins, Intravenous
×
Thoracic
×
Clear all
NCT06064279
2024-09-19
HAITEN-ICI
VA Office of Research and Development
Phase 1/2
Withdrawn